Literature DB >> 7438983

Ecology of Mooren's ulcer in Nigeria.

A A Majekodunmi.   

Abstract

Five cases of Mooren's ulcer in young Nigerians seen over a 2-year period, in Lagos, healed after limbal conjunctivectomy. The maximum follow up in 2 cases was 2 years. Previous trauma or corneal foreign bodies as seen in four of our cases seem to suggest the precipitation of Mooren's ulcer by various ocular insults. We believe that collagenolytic activity of the conjunctiva plays a prominent role in the pathogenesis of the ulcer and is supported by this report in which our five cases healed after excision of the limbal conjunctiva. Helminthosis, found in four of our five patients with Mooren's ulcer in an endemic area, such as Nigeria may be an associated finding. The presence of lymphocytes and plasma cells in the histopathology of the excised tissue in one of our cases is suggestive of an autoimmune phenomenon in this disease.

Entities:  

Mesh:

Year:  1980        PMID: 7438983     DOI: 10.1007/bf01886619

Source DB:  PubMed          Journal:  Doc Ophthalmol        ISSN: 0012-4486            Impact factor:   2.379


  8 in total

1.  Surgical therapy of Mooren's ulcer: Report of two cases successfully treated.

Authors:  J M Christiansen; J J Arentsen
Journal:  Ann Ophthalmol       Date:  1975-11

2.  Mooren's ulcer. Etiology and treatment.

Authors:  E T KURIAKOSE
Journal:  Am J Ophthalmol       Date:  1963-05       Impact factor: 5.258

3.  Circulating antibodies to corneal tissue in a patient suffering from Mooren's ulcer (ulcus rodens corneae).

Authors:  O L Schaap; T E Feltkamp; A C Breebaart
Journal:  Clin Exp Immunol       Date:  1969-10       Impact factor: 4.330

4.  Combined cryoapplications and peritomy in Mooren's ulcer.

Authors:  E Aviel
Journal:  Br J Ophthalmol       Date:  1972-01       Impact factor: 4.638

5.  Mooren's ulcer.

Authors:  T O Wood; H E Kaufman
Journal:  Am J Ophthalmol       Date:  1971-01       Impact factor: 5.258

6.  Mooren's ulcer in Nigeria.

Authors:  B Kietzman
Journal:  Am J Ophthalmol       Date:  1968-05       Impact factor: 5.258

7.  Mooren's ulcer. Treatment by conjunctival excision.

Authors:  S I Brown
Journal:  Br J Ophthalmol       Date:  1975-11       Impact factor: 4.638

8.  Chronic serpiginous ulcer of the cornea (Moreen's ulcer) etiologic and therapeutic considerations.

Authors:  J G LINN
Journal:  Am J Ophthalmol       Date:  1949-05       Impact factor: 5.258

  8 in total
  7 in total

1.  Bilateral Mooren's ulcer in a child secondary to helminthic infestation of the gastrointestinal tract.

Authors:  Prakashchand Agarwal; Digvijay Singh; Gautam Sinha; Namrata Sharma; Jeewan Singh Titiyal
Journal:  Int Ophthalmol       Date:  2012-06-03       Impact factor: 2.031

2.  Mooren'S ulcer in ibadan, southwest Nigeria.

Authors:  O Fasina; Ao Ogundipe; Ei Ezichi
Journal:  J West Afr Coll Surg       Date:  2013 Jul-Sep

3.  Clinical characteristics of Mooren's ulcer in South India.

Authors:  Muthaiah Srinivasan; Michael E Zegans; Joseph R Zelefsky; Arunava Kundu; Thomas Lietman; John P Whitcher; Emmett T Cunningham
Journal:  Br J Ophthalmol       Date:  2006-10-11       Impact factor: 4.638

4.  Calgranulin C has filariacidal and filariastatic activity.

Authors:  J D Gottsch; S W Eisinger; S H Liu; A L Scott
Journal:  Infect Immun       Date:  1999-12       Impact factor: 3.441

5.  Cloning and sequence analysis of human and bovine corneal antigen (CO-Ag) cDNA: identification of host-parasite protein calgranulin C.

Authors:  J D Gottsch; W J Stark; S H Liu
Journal:  Trans Am Ophthalmol Soc       Date:  1997

6.  Circulating antibodies against corneal epithelium and hookworm in patients with Mooren's ulcer from Sierra Leone.

Authors:  R van der Gaag; H Abdillahi; J S Stilma; J C Vetter
Journal:  Br J Ophthalmol       Date:  1983-09       Impact factor: 4.638

7.  Conjunctival excision or lamellar scleral autograft in 38 Mooren's ulcers from Sierra Leone.

Authors:  J S Stilma
Journal:  Br J Ophthalmol       Date:  1983-07       Impact factor: 4.638

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.